Elon Musk’s brain implant company Neuralink says it has US approval to begin trials in people - Terrace Standard

  • 📰 TerraceStandard
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 68%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Elon Musk’s brain implant company Neuralink says it has US approval to begin trials in people

, with ultra-thin wires going directly into the brain. Musk has said the first two applications in people would be to attempt to restore vision and try to help people with little or no ability to operate their muscles rapidly use digital devices. He also said he envisions that signals from the brain could be bridged to Neuralink devices in the spinal cord for someone with a broken neck.

After Musk made a presentation late last year about the device, Rajesh Rao, co-director of the Center for Neurotechnology at the University of Washington, said he doesn’t think Neuralink is ahead of other teams in terms of brain-computer interface achievements but is “quite ahead” in terms of the hardware in the devices.

It’s unclear how well this device or similar interfaces will ultimately work, or how safe they might be. Neuralink’s interface is considered an “investigational device” at this point, and clinical trials are designed to collect data on safety and effectiveness. In its tweet this week, Neuralink said that it’s not yet recruiting participants for the study and will provide more information soon.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 24. in İD

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Brain implant company Neuralink says it has U.S. approval to begin trials in peopleElon Musk’s company made the announcement on Twitter Thursday evening but has provided no details about a potential study, which was not listed on the U.S. government database of clinical trials
Sumber: globeandmail - 🏆 5. / 92 Baca lebih lajut »